Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer

Abstract

It is impossible to predict which postmenopausal women will develop pathological endometrial changes after treatment with tamoxifen and thus a routine periodic endometrial sampling-follow up is suggested for all postmenopausal women being treated with this agent.